Comment
. 2004 Dec;10(12):1278-9; author reply 1279-80.
doi: 10.1038/nm1204-1278.
Cancer vaccines: pessimism in check
- PMID: 15580242
- DOI: 10.1038/nm1204-1278
Item in Clipboard
Comment
Cancer vaccines: pessimism in check
Nat Med.
2004 Dec.
No abstract available
Comment on
-
Cancer immunotherapy: moving beyond current vaccines.Nat Med. 2004 Sep;10(9):909-15. doi: 10.1038/nm1100. Nat Med. 2004. PMID: 15340416 Free PMC article.
Similar articles
-
Cancer vaccines: pessimism in check.Nat Med. 2004 Dec;10(12):1279; author reply 1279-80. doi: 10.1038/nm1204-1279a. Nat Med. 2004. PMID: 15682512 No abstract available.
-
Immunotherapy of metastasis.Surg Oncol Clin N Am. 2001 Apr;10(2):433-47, xi. Surg Oncol Clin N Am. 2001. PMID: 11382596 Review.
-
Cellular and humoral immune responses of cancer patients to defined tumor antigens.Cancer Chemother Biol Response Modif. 2001;19:385-93. Cancer Chemother Biol Response Modif. 2001. PMID: 11686025 Review. No abstract available.
-
[Perspectives for tumour immunology: antigen-specific immunotherapy of malignant diseases].Dtsch Med Wochenschr. 2001 Sep 14;126(37):1011-6. doi: 10.1055/s-2001-17111. Dtsch Med Wochenschr. 2001. PMID: 11555776 Review. German. No abstract available.
-
Cancer immunotherapy: a treatment for the masses.Science. 2004 Jul 9;305(5681):200-5. doi: 10.1126/science.1100369. Science. 2004. PMID: 15247469 Review.
Cited by
-
Lectin of Concanavalin A as an anti-hepatoma therapeutic agent.J Biomed Sci. 2009 Jan 19;16(1):10. doi: 10.1186/1423-0127-16-10. J Biomed Sci. 2009. PMID: 19272170 Free PMC article. Review.
-
Analysis of vaccine-induced T cells in humans with cancer.Adv Exp Med Biol. 2010;684:178-88. doi: 10.1007/978-1-4419-6451-9_14. Adv Exp Med Biol. 2010. PMID: 20795549 Free PMC article.
-
Reflections upon human cancer immune responsiveness to T cell-based therapy.Cancer Immunol Immunother. 2012 Jun;61(6):761-70. doi: 10.1007/s00262-012-1274-9. Epub 2012 May 11. Cancer Immunol Immunother. 2012. PMID: 22576055 Free PMC article. Review.
-
A balanced review of the status T cell-based therapy against cancer.J Transl Med. 2005 Apr 14;3(1):16. doi: 10.1186/1479-5876-3-16. J Transl Med. 2005. PMID: 15831096 Free PMC article.
-
Culture of melanoma cells in 3-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor-associated antigen.Ann Surg. 2005 Dec;242(6):851-7, discussion 858. doi: 10.1097/01.sla.0000189571.84213.b0. Ann Surg. 2005. PMID: 16327495 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
